Suppr超能文献

起源于滤泡中心细胞的淋巴瘤中S-100蛋白、纤连蛋白和层粘连蛋白的免疫染色

S-100 protein, fibronectin, and laminin immunostaining in lymphomas of follicular center cell origin.

作者信息

Carbone A, Manconi R, Poletti A, Colombatti A, Tirelli U, Volpe R

出版信息

Cancer. 1986 Nov 15;58(10):2169-76. doi: 10.1002/1097-0142(19861115)58:10<2169::aid-cncr2820581002>3.0.co;2-m.

Abstract

Forty-nine paraffin-embedded biopsy specimens of involved nodal and extranodal tissue (bone marrow, spleen, and liver) from 13 patients with follicular center cell lymphomas (FCCL) and 14 with small lymphocytic lymphomas (SLL), including 11 cases with chronic lymphocytic leukemia, were tested for S-100 protein immunoreactivity. Analysis for fibronectin and laminin immunoreactivities was limited to the lymph node biopsy specimens. In FCCL, S-100-positive dendritic reticulum cells (DRCs) were found in 23 of the 26 tissue specimens examined, regardless of the involved sites and the growth pattern. Cases with completely or predominantly follicular pattern were usually associated with a spherical meshwork pattern of S-100-positive DRCs; in the FCCL specimens with a diffuse pattern (lymph nodes and bone marrow) as well as in the specimen areas with a minimally follicular tumor pattern, S-100-positive DRCs were consistently fewer in number and composed loosely aggregated nests. No S-100-positive DRCs were found in all the biopsy specimens in SLL. Concerning fibronectin and laminin immunostainings, results showed that no differences were present between areas of follicular and diffuse neoplastic growth and that the neoplastic growth of FCCL maintained for each antiserum the same distribution pattern as that seen in normal follicles. Analysis of the microenvironmental components as revealed with antisera used in the current study--particularly with anti-S-100 protein antiserum--appears to be a useful adjunct for the identification of FCCL in paraffin-embedded biopsy specimens, especially in extranodal sites.

摘要

对13例滤泡中心细胞淋巴瘤(FCCL)患者和14例小淋巴细胞淋巴瘤(SLL)患者(包括11例慢性淋巴细胞白血病患者)的49份受累淋巴结及结外组织(骨髓、脾脏和肝脏)石蜡包埋活检标本进行了S-100蛋白免疫反应性检测。纤连蛋白和层粘连蛋白免疫反应性分析仅限于淋巴结活检标本。在FCCL中,在所检查的26份组织标本中的23份中发现了S-100阳性树突状网状细胞(DRC),无论受累部位和生长模式如何。完全或主要为滤泡型的病例通常与S-100阳性DRC的球形网状模式相关;在具有弥漫型(淋巴结和骨髓)的FCCL标本以及具有最小滤泡性肿瘤模式的标本区域中,S-100阳性DRC的数量始终较少,且由松散聚集的巢组成。在SLL的所有活检标本中均未发现S-100阳性DRC。关于纤连蛋白和层粘连蛋白免疫染色,结果显示滤泡性和弥漫性肿瘤生长区域之间没有差异,并且FCCL的肿瘤生长对于每种抗血清保持与正常滤泡中所见相同的分布模式。用本研究中使用的抗血清揭示的微环境成分分析——特别是抗S-100蛋白抗血清——似乎是鉴定石蜡包埋活检标本中FCCL的有用辅助手段,尤其是在结外部位。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验